The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 07th Oct 2014 09:45

African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation.Aggreko: Exane initiates with a target price of 1500p and an underperform rating.Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation.Antofagasta: Canaccord Genuity reduces target price from 835p to 790p maintaining a hold recommendation. Nomura cuts target price from 720p to 700p, while upgrading to neutral.Arrow Global: Numis raises target price from 287p to 326p upgrading to buy.AstraZeneca: Deutsche Bank raises target price from 4000p to 4100p and stays with its hold recommendation. Panmure Gordon raises target price from 4400p to 4700p upgrading from hold to buy.Avon Rubber: N+1 Singer ups target price from 720p to 750p and keeps its buy recommendation.BAE Systems: Cantor Fitzgerald downgrades to hold with a target price of 460p.BHP Billiton: Canaccord Genuity cuts target price from 2020p to 1950p and retains a hold recommendation.BTG: Deutsche Bank raises target price from 655p to 745p keeping a buy recommendation.Central Asia Metals: Canaccord Genuity ups target price from 190p to 210p keeping a buy recommendation.Cranswick: N+1 Singer reduces target price from 1291p to 1246p reiterating a hold recommendation.Dixons Carphone: UBS initiates with a target price of 415p and a buy recommendation.easyJet: JP Morgan reduces target price from 1909p to 1815p and keeps an overweight rating.GlaxoSmithKline: Deutsche Bank cuts target price from 1450p to 1420p staying with a hold recommendation.Gooch & Housego: Investec cuts target price from 740p to 720p downgrading to add.Hummingbird Reources: Northland lowers target price from 98p to 94.2p and reiterates a buy recommendation.Hunting: Liberum Capital cuts target price from 802p to 763p downgrading to sell.ITE Group: Westhouse Securities cuts target price from 216p to 193p, while upgrading from neutral to add.John Wood Group: Liberum Capital reduces target price from 736p to 610p downgrading to sell.Kazakhmys: Canaccord Genuity ups target price from 260p to 280p maintaining a hold recommendation.Management Consulting: Canaccord Genuity lowers target price from 28p to 22p downgrading from buy to a speculative buy recommendation. Peel Hunt lowers target price from 30p to 21p and downgrades from buy to hold.Metminco: Canaccord Genuity lowers target price from 10p to 70p and keeps its speculative buy recommendation.Next Fifteen Communications: Canaccord Genuity shifts target price from 145p to 151p retaining a buy recommendation. Investec sOrsu Metals: Canaccord Genuity lowers target price from 4p to 3p and stays with its speculative buy recommendation.Petroceltic: Westhouse Securities downgrades to neutral with a target price of 240p.Petrofac: Liberum Capital reduces target price from 1223p to 1112p and keeps a hold recommendation.Pure Wafer: WH Ireland cuts target price from 115p to 96p, while leaving its buy recommendation unchanged.Rio Tinto: Canaccord Genuity reduces target price from 4165p to 4080p staying with its buy recommendation.Robert Walters: Oriel upgrades from add to buy.Sinclair IS Pharma: N+1 Singer lowers target price from 40p to 36p maintaining a buy recommendation.Spirent: Investec cuts target price from 105p to 80p, while its hold recommendation is kept.
More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.